Last updated: July 17, 2026

Application No. 18/668,774

METHODS OF TREATING CANCER WITH PI3K INHIBITOR, GDC-0077

Non-Final OA

Filed

May 20, 2024

Priority

Jul 23, 2018 — provisional 62/702,197 +3 more

Examiner

BAEK, BONG-SOOK

Art Unit

1611

Tech Center

1600 — Biotechnology & Organic Chemistry

Assignee

Genentech Inc.

OA Round

1 (Non-Final)

This examiner grants 42% of cases after interview

— +69.6% interview lift. A telephonic interview to clarify the technical implementation could significantly improve the outcome.

Based on 916 resolved cases, 2023–2026

Examiner Intelligence

BAEK, BONG-SOOK View full profile →

Grants 42% of resolved cases

Career Allowance Rate

380 granted / 916 resolved

-18.5% vs TC avg

Strong +70% interview lift

Without

With

+69.6%

Interview Lift

resolved cases with interview

Typical timeline

3y 1m

Avg Prosecution

42 currently pending

Career history

961

Total Applications

across all art units

Statute-Specific Performance

§101

1.1%

-38.9% vs TC avg

§103

50.4%

+10.4% vs TC avg

§102

6.5%

-33.5% vs TC avg

§112

4.1%

-35.9% vs TC avg

Black line = Tech Center average estimate • Based on career data from 916 resolved cases

Prosecution Timeline

May 20, 2024

Application Filed

Mar 17, 2026

Non-Final Rejection mailed (current)

Precedent Cases

Applications granted by this same examiner with similar technology

18/152,303

Patent 12653820

HYDROMORPHONE FORMULATIONS FOR MULTI-DOSE PRODUCTS

3y 5m to grant Granted Jun 16, 2026

18/491,880

Patent 12636315

METHOD FOR TREATING PERIODONTAL DISEASE

2y 7m to grant Granted May 26, 2026

17/773,213

Patent 12611394

USE OF GINKGOLIDE A IN THE TREATMENT OF AUTISM

4y 0m to grant Granted Apr 28, 2026

18/397,644

Patent 12605331

NOVEL COMPOSITION COMPRISING IRIS-DERIVED EXOSOME AS ACTIVE INGREDIENT

2y 3m to grant Granted Apr 21, 2026

18/579,456

Patent 12605464

CYCLOHEXANE LIPIDOIDS FOR NUCLEIC ACID TRANSFECTION AND USE THEREOF

2y 3m to grant Granted Apr 21, 2026

Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.

Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2

Expected OA Rounds

42%

Grant Probability

99%

With Interview (+69.6%)

3y 1m (~11m remaining)

Median Time to Grant

Low

PTA Risk

Based on 916 resolved cases by this examiner. Grant probability derived from career allowance rate.